- Home
- CYBN vs FSP Comparison
CYBN vs FSP Comparison
Compare CYBN & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- FSP
- Stock Information
- Founded
- CYBN 2019
- FSP 1981
- Country
- CYBN Canada
- FSP United States
- Employees
- CYBN N/A
- FSP N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- FSP Real Estate Investment Trusts
- Sector
- CYBN Health Care
- FSP Real Estate
- Exchange
- CYBN Nasdaq
- FSP Nasdaq
- Market Cap
- CYBN 176.5M
- FSP 165.9M
- IPO Year
- CYBN N/A
- FSP N/A
- Fundamental
- Price
- CYBN $5.90
- FSP $1.46
- Analyst Decision
- CYBN Strong Buy
- FSP
- Analyst Count
- CYBN 3
- FSP 0
- Target Price
- CYBN $85.00
- FSP N/A
- AVG Volume (30 Days)
- CYBN 700.6K
- FSP 403.7K
- Earning Date
- CYBN 11-12-2025
- FSP 10-28-2025
- Dividend Yield
- CYBN N/A
- FSP 2.67%
- EPS Growth
- CYBN N/A
- FSP N/A
- EPS
- CYBN N/A
- FSP N/A
- Revenue
- CYBN N/A
- FSP $111,879,000.00
- Revenue This Year
- CYBN N/A
- FSP $4.36
- Revenue Next Year
- CYBN N/A
- FSP $0.81
- P/E Ratio
- CYBN N/A
- FSP N/A
- Revenue Growth
- CYBN N/A
- FSP N/A
- 52 Week Low
- CYBN $4.81
- FSP $1.36
- 52 Week High
- CYBN $13.88
- FSP $2.21
- Technical
- Relative Strength Index (RSI)
- CYBN 45.57
- FSP 26.34
- Support Level
- CYBN $5.93
- FSP $1.58
- Resistance Level
- CYBN $6.63
- FSP $1.60
- Average True Range (ATR)
- CYBN 0.32
- FSP 0.05
- MACD
- CYBN 0.03
- FSP -0.02
- Stochastic Oscillator
- CYBN 30.77
- FSP 5.77
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.